Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Toru Kawanishi | Co-Founder & Executive Chairman | -- | -- | 1967 |
| Mr. Keita Mori MBA | Co-Founder, President, Executive Officer, CEO & Representative Director | -- | -- | 1967 |
| Mr. Yoshihiro Kakutani | Corporate Officer of Management Administration | -- | -- | -- |
| Mr. Greg Gillas | Senior Vice President of Human Resources & Corporate Services | -- | -- | -- |
| Mr. Naoki Tsukahara | Senior Corporate Officer | -- | -- | -- |
| Dr. Kazumi Sawaguchi Ph.D. | Corporate Officer and Head of Japan Regulatory Affairs & Quality Compliance Japan | -- | -- | -- |
| Mr. Keizo Nakada | Corporate Officer & Head of Production | -- | -- | -- |
| Shinya Hirata | Corporate Officer & Head of Research and Development | -- | -- | -- |
| Mr. Dai Chida | Senior Scientific Advisor | -- | -- | -- |
| Masumi Akahori | In charge of IR | -- | -- | -- |
SanBio Company Limited
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 29
Description
SanBio Company Limited develops, produces, and sells regenerative cell medicines for the central nervous system. The company develops SB623 that has completed a phase 2 clinical trial to treat traumatic brain injury in the United States and Japan. Its research pipeline products also comprise SB623 for ischemic and hemorrhagic strokes, age-related macular degeneration, retinitis pigments, Parkinson's disease, spinal cord injury, and Alzheimer's disease; SB618 for peripheral nerve damage; SB308 for muscular dystrophy disease; MSC1 for cancer; and MSC2 for inflammatory disease and optic neuritis. The company was founded in 2001 and is headquartered in Tokyo, Japan.
Corporate Governance
Upcoming Events
December 16, 2024 at 6:00 AM UTC
SanBio Company Limited Earnings Date
Recent Events
Recent Events Information Not Available